NXTC
Income statement / Annual
Last year (2024), NextCure, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, NextCure, Inc.'s net income was -$55.65 M.
See NextCure, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$22.38 M |
$6.35 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$46.55 M
|
$34.22 M
|
$1.68 M
|
$582.00 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$24.18 M
|
-$27.87 M
|
-$1.68 M
|
-$582.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
-1.08
|
-4.39
|
0
|
0
|
| Research and Development Expenses |
$41.49 M
|
$47.93 M
|
$54.20 M
|
$50.19 M
|
$46.55 M
|
$34.22 M
|
$19.79 M
|
$12.95 M
|
| General & Administrative Expenses |
$15.72 M
|
$19.71 M
|
$21.71 M
|
$20.57 M
|
$17.05 M
|
$9.61 M
|
$3.41 M
|
$2.60 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$15.72 M
|
$19.71 M
|
$21.71 M
|
$20.57 M
|
$17.05 M
|
$9.61 M
|
$3.41 M
|
$2.60 M
|
| Other Expenses |
$2.54 M
|
$0.00
|
$0.00
|
$0.00
|
-$46.55 M
|
-$34.22 M
|
$397.00 K
|
$80.00 K
|
| Operating Expenses |
$59.75 M
|
$67.64 M
|
$75.91 M
|
$70.77 M
|
$17.05 M
|
$9.61 M
|
$23.20 M
|
$15.55 M
|
| Cost And Expenses |
$59.75 M
|
$67.64 M
|
$75.91 M
|
$70.77 M
|
$63.60 M
|
$43.83 M
|
$23.20 M
|
$15.55 M
|
| Interest Income |
$0.00
|
$0.00
|
$1.17 M
|
$1.32 K
|
$4.55 K
|
$3.75 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$77.00 K
|
$183.00 K
|
$209.00 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$2.87 M
|
$3.68 M
|
$4.12 M
|
$4.18 M
|
$3.41 M
|
$2.69 M
|
$1.68 M
|
$582.00 K
|
| EBITDA |
-$54.34 M |
-$63.95 M |
-$71.79 M |
-$66.59 M |
-$37.81 M |
-$34.79 M |
-$21.10 M |
-$14.97 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-1.69
|
-5.48
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-1.84
|
-5.91
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.09 M
|
$4.91 M
|
$1.18 M
|
$1.38 M
|
$4.62 M
|
$3.75 M
|
$397.00 K
|
$80.00 K
|
| Income Before Tax |
-$55.65 M
|
-$62.72 M
|
-$74.73 M
|
-$69.39 M
|
-$36.60 M
|
-$33.74 M
|
-$22.80 M
|
-$15.47 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-1.64
|
-5.32
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$55.65 M
|
-$62.72 M
|
-$74.73 M
|
-$69.39 M
|
-$36.60 M
|
-$33.74 M
|
-$22.80 M
|
-$15.47 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-1.64
|
-5.32
|
0
|
0
|
| EPS |
-23.88 |
-27.0391 |
-32.3237 |
-30.1517 |
-15.9535 |
-25.7936 |
-12.0445 |
-8.1721 |
| EPS Diluted |
-23.88 |
-27.0391 |
-32.3237 |
-30.1517 |
-15.9535 |
-25.7936 |
-12.0445 |
-8.1721 |
| Weighted Average Shares Out |
$2.33 M
|
$2.32 M
|
$2.31 M
|
$2.30 M
|
$2.29 M
|
$1.31 M
|
$1.89 M
|
$1.89 M
|
| Weighted Average Shares Out Diluted |
$2.33 M
|
$2.32 M
|
$2.31 M
|
$2.30 M
|
$2.29 M
|
$1.31 M
|
$1.89 M
|
$1.89 M
|
| Link |
|
|
|
|
|
|
|
|
